RachaelMorton - International Society of Nephrology Events

Professor of Health Economics, Principal Investigator of the Symptom Monitoring with Feedback Trial (SWIFT), an ANZDATA Registry cluster-randomised trial of electronic patient reported outcome measures among adults receiving haemodialysis.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/62076f9cab32c5cdbfd759fad658a89e.jpg

First name

Rachael

Last name

Morton

Institution

Country

Australia

Thursday, February 6, 2025

Time	Session

2:45 p.m. 4:05 p.m.	ISN SharE-RR - Sharing Expertise to Support the Set-up of Renal Registries: Using Registries to Support Clinical Trials SHARE RR2 MegJardine Chair AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia ShilpanjaliJesudason Chair AustraliaRoyal Adelaide Hospital and University of Adelaide, Australia Using Registry Data in Trials: Lessons on Patient Reported Outcomes from SWIFT in Australia SHARE RR2-001 RachaelMorton Speaker AustraliaNHMRC Clinical Trials Centre, The University of Sydney Using Registry Data in Trials: Defining Measures of Kidney Function in Observational Studies Using Routine Health Care Data SHARE RR2-002 Juan-JesusCarrero Speaker SwedenKarolinska Institutet Using Registry Data in Trials: Lessons from Tackling AKI, H4RT, and Prepare for Kidney Care in the UK SHARE RR2-003 FergusCaskey Speaker United KingdomUniversity of Bristol, UK Q and A SHARE RR2-004 Kesar Hall 202

Time

Session

2:45 p.m.

4:05 p.m.

ISN SharE-RR - Sharing Expertise to Support the Set-up of Renal Registries: Using Registries to Support Clinical Trials

SHARE RR2

MegJardine Chair AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia

ShilpanjaliJesudason Chair AustraliaRoyal Adelaide Hospital and University of Adelaide, Australia

Using Registry Data in Trials: Lessons on Patient Reported Outcomes from SWIFT in Australia

SHARE RR2-001

RachaelMorton Speaker AustraliaNHMRC Clinical Trials Centre, The University of Sydney
Using Registry Data in Trials: Defining Measures of Kidney Function in Observational Studies Using Routine Health Care Data

SHARE RR2-002

Juan-JesusCarrero Speaker SwedenKarolinska Institutet
Using Registry Data in Trials: Lessons from Tackling AKI, H4RT, and Prepare for Kidney Care in the UK

SHARE RR2-003

FergusCaskey Speaker United KingdomUniversity of Bristol, UK
Q and A

SHARE RR2-004

Kesar Hall 202

RachaelMorton AustraliaNHMRC Clinical Trials Centre, The University of Sydney

Thursday, February 6, 2025